glp 1 agonist brands glp-1 receptor brand names Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market Report ANSE1024_0051_table_a.jpg
Description
Reported side effects may include nausea, vomiting, diarrhea, and constipation, among others
[DOI] [PubMed] [Google Scholar] 132.DeVries JH, Bain SC, Rodbard HW, Seufert J, D'Alessio D, Thomsen AB, Zychma M, Rosenstock J Liraglutide-Detemir Study Group
Glucagon-like peptide 1 analogue therapy directly modulates innate immunemediated inflammation in individuals with type 2 diabetes mellitus
Notably, if we compare two different studies (with different patient populations, admittedly), the prevalence of nausea and vomiting was much higher in patients taking 2.4 mg semaglutide subcutaneously 3 than in those taking 0.5 and 1 mg 1 (44% vs 2% and 5% for nausea and 31% vs 2% and 3% for vomiting, respectively)
Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al
Heres What Might Be Going On Get more of SELF's great service journalism delivered right to your inbox.
